168 related articles for article (PubMed ID: 9692108)
1. Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions.
Perng RP; Chen YM; Wu MF; Chou KC; Lin WC; Liu JM; Whang-Peng J
Respir Med; 1998 Mar; 92(3):473-9. PubMed ID: 9692108
[TBL] [Abstract][Full Text] [Related]
2. Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis.
Lombardi G; Nicoletto MO; Gusella M; Fiduccia P; Dalla Palma M; Zuin A; Fiore D; Donach M; Zagonel V
Cancer Chemother Pharmacol; 2012 Mar; 69(3):781-7. PubMed ID: 22037881
[TBL] [Abstract][Full Text] [Related]
3. A phase I clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions.
Wang X; Zhou J; Wang Y; Zhu Z; Lu Y; Wei Y; Chen L
Eur J Cancer; 2010 May; 46(8):1474-80. PubMed ID: 20207133
[TBL] [Abstract][Full Text] [Related]
4. Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer.
Tohda Y; Iwanaga T; Takada M; Yana T; Kawahara M; Negoro S; Okishio K; Kudoh S; Fukuoka M; Furuse K
Chemotherapy; 1999; 45(3):197-204. PubMed ID: 10224342
[TBL] [Abstract][Full Text] [Related]
5. A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions.
Perng RP; Wu MF; Lin SY; Chen YM; Lin JY; Whang-Peng J
Anticancer Drugs; 1997 Jul; 8(6):565-73. PubMed ID: 9300570
[TBL] [Abstract][Full Text] [Related]
6. Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non-small-cell lung cancer: a multi-institutional phase II trial.
Seto T; Ushijima S; Yamamoto H; Ito K; Araki J; Inoue Y; Semba H; Ichinose Y;
Br J Cancer; 2006 Sep; 95(6):717-21. PubMed ID: 16940982
[TBL] [Abstract][Full Text] [Related]
7. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
[TBL] [Abstract][Full Text] [Related]
8. A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non-small-cell lung cancer.
Nie K; Zhang Z; You Y; Zhuang X; Zhang C; Ji Y
Thorac Cancer; 2020 Jan; 11(1):8-14. PubMed ID: 31726490
[TBL] [Abstract][Full Text] [Related]
9. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial.
Rusch VW; Figlin R; Godwin D; Piantadosi S
J Clin Oncol; 1991 Feb; 9(2):313-9. PubMed ID: 1988578
[TBL] [Abstract][Full Text] [Related]
10. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
Ishida A; Miyazawa T; Miyazu Y; Iwamoto Y; Zaima M; Kanoh K; Sumiyoshi H; Doi M
Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
[TBL] [Abstract][Full Text] [Related]
11. The clinical efficacy and safety of paclitaxel combined with avastin for NSCLC patients diagnosed with malignant pleural effusion.
Wang Z; Zheng Y; Fang Z
Rev Assoc Med Bras (1992); 2018 Mar; 64(3):230-233. PubMed ID: 29641777
[TBL] [Abstract][Full Text] [Related]
12. Vandetanib and indwelling pleural catheter for non-small-cell lung cancer with recurrent malignant pleural effusion.
Massarelli E; Onn A; Marom EM; Alden CM; Liu DD; Tran HT; Mino B; Wistuba II; Faiz SA; Bashoura L; Eapen GA; Morice RC; Jack Lee J; Hong WK; Herbst RS; Jimenez CA
Clin Lung Cancer; 2014 Sep; 15(5):379-86. PubMed ID: 24913066
[TBL] [Abstract][Full Text] [Related]
13. Intrapleural combination therapy with lobaplatin and erythromycin for non-small cell lung cancer-mediated malignant pleural effusion.
Xu L; Wang B; Gao M; Zhang Y; Qi Q; Li T; Li C; Wang A; Li Y
Thorac Cancer; 2018 Aug; 9(8):950-955. PubMed ID: 29917319
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: a phase II trial.
Gatzemeier U; Heckmayer M; Neuhauss R; Schlüter I; von Pawel J; Wagner H; Dreps A
Semin Oncol; 1995 Dec; 22(6 Suppl 15):24-8. PubMed ID: 8643966
[TBL] [Abstract][Full Text] [Related]
15. Effect of medical thoracoscopy-guided intrapleural docetaxel therapy to manage malignant pleural effusion in patients with non-small cell lung cancer: A pilot study.
Choi MG; Park S; Oh DK; Kim HR; Lee GD; Lee JC; Choi CM; Ji W
Thorac Cancer; 2019 Oct; 10(10):1885-1892. PubMed ID: 31389192
[TBL] [Abstract][Full Text] [Related]
16. Intrapleural chemotherapy without pleurodesis for malignant pleural effusions. LCSG Trial 861.
Figlin R; Mendoza E; Piantadosi S; Rusch V
Chest; 1994 Dec; 106(6 Suppl):363S-366S. PubMed ID: 7988265
[TBL] [Abstract][Full Text] [Related]
17. One-hour paclitaxel plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicentre, phase II trial.
Hainsworth JD; Urba WJ; Hon JK; Thompson KA; Stagg MP; Hopkins LG; Thomas M; Greco FA
Eur J Cancer; 1998 Apr; 34(5):654-8. PubMed ID: 9713269
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-guided small-bore Elecath tube insertion for the rapid sclerotherapy of malignant pleural effusion.
Hsu WH; Chiang CD; Chen CY; Kwan PC; Hsu JY
Jpn J Clin Oncol; 1998 Mar; 28(3):187-91. PubMed ID: 9614441
[TBL] [Abstract][Full Text] [Related]
19. Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.
Tamiya M; Tamiya A; Yasue T; Nakao K; Omachi N; Shiroyama T; Tani E; Hamaguchi M; Morishita N; Suzuki H; Okamoto N; Okishio K; Kawaguchi T; Atagi S; Hirashima T
Anticancer Res; 2016 Jun; 36(6):2939-44. PubMed ID: 27272808
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer.
Kasahara K; Shibata K; Shintani H; Iwasa K; Sone T; Kimura H; Nobata K; Hirose T; Yoshimi Y; Katayama N; Ishiura Y; Kita T; Nishi K; Nakatsumi Y; Ryoma Y; Fujimura M; Nakao S
Anticancer Res; 2006; 26(2B):1495-9. PubMed ID: 16619563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
